Clinical Trials Browser

Completed × toripalimab × Lymphoid × Clear all

NCT03316144 2020-09-30

Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of Toripalimab for Patients With Recurrent Malignant Lymphoma

Phase 1 Completed

Lymphoma